Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)

NCT05097989 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

100

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision.

Conditions

Lupus Nephritis
Immunoglobulin A Nephropathy
IgAN
LN

Interventions

DRUG: ALXN2050
DRUG: Placebo

Sponsor

Alexion Pharmaceuticals, Inc.